[1. Magliozzi R, Columba Cabezas S, Serafini B, Aloisi F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol. 2004 Mar;148(1-2):11-23. DOI: 10.1016/j.jneuroim.2003.10.056.10.1016/j.jneuroim.2003.10.056]Search in Google Scholar
[2. Kowarik MC, Cepoc S, Sellner J, Grumel V, Weber M, Korn T, et al. CXCL13 is a major determinant for B cell recruitment to the CSF during neuroinflammation. J of Neuroinflamm. 2012 May;9:93. DOI: 10.1186/1742-2094-9-93.10.1186/1742-2094-9-93]Search in Google Scholar
[3. Hytonen J, Kortela E, Waris M, Puustinen J, Oksi J. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. J of Neuroinflamm. 2014 Jun;11:103. DOI: 10.1186/1742-2094-11-103.10.1186/1742-2094-11-103]Search in Google Scholar
[4. Bremell D, Mattsson N, Edsbagge M, Blennow K, Andreasson U, Wikkelso C, et al. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol. 2013 Jan;13:2. DOI: 10.1186/1471-2377-13-2.10.1186/1471-2377-13-2]Search in Google Scholar
[5. Fujimori J, Nakashima I, Kuroda H, Fujihara K, Aoki M. Cerebrospinal fluid CXCL13 a prognostic marker for aseptic meningitis. J Neuroimmunol. 2014 Aug; 273(1-2):77-84. DOI: 10.1016/j.jneuroim.2014.05.008.10.1016/j.jneuroim.2014.05.008]Search in Google Scholar
[6. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain. 2006 Jan; 129(Pt1):200-11.10.1093/brain/awh680]Search in Google Scholar
[7. Schmidt C, Plate A, Angele B, Pfister H-W, Wick M, Koede U, et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology. 2011 Mar;76 (12):1051-8. DOI: 10.1212/WNL.0b013e318211c39a.10.1212/WNL.0b013e318211c39a]Search in Google Scholar
[8. van Burgel ND, Bakels F, Kroes ACM, van Dam AP. Discriminating Lyme Neuroborreliosis from other Neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid. J Clin Microbial. 2011 May;49(5):2027-30. DOI: 10.1128/JCM.00084-11.10.1128/JCM.00084-11]Search in Google Scholar
[9. Stanek G, Wormser GP, Gray J, Srtle F. Lyme borreliosis. Lancet. 2012 Feb; 379(9814):461-73. DOI: 10.1016/S0140-6736(11)60103-7.10.1016/S0140-6736(11)60103-7]Search in Google Scholar
[10. Mygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010 Jan;17(1):8-16. DOI: 10.1111/j.1468-1331.2009.02862.x.10.1111/j.1468-1331.2009.02862.x]Search in Google Scholar
[11. Lalor SJ, Segal BM. Lymphoid chemokines in the CNS. J Neuroimmunol. 2010 Jul;224(1-2):56-61. DOI: 10.1016/j.jneuroim.2010.05.017.10.1016/j.jneuroim.2010.05.017]Search in Google Scholar
[12. Wutte N, Berghold A, Löffler S, Zenz W, Daghofer E, Krainberger I, et al. CXCL13 chemokine in paediatric and adult neuroborreliosis. Acta Neurol Scand. 2011 Nov;124(5):321-8. DOI: 10.1111/j.1600-0404.2010.01477.x.10.1111/j.1600-0404.2010.01477.x]Search in Google Scholar
[13. Ljøstad U, Mygland A. CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of Lyme neuroborreliosis. J Neurol. 2008 May;255(5):732-7. DOI: 10.1007/s00415-008-0785-y DOI: 10.1007/s00415-008-0974-8.10.1007/s00415-008-0785-y]Search in Google Scholar
[14. Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, et al. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther. 2010 Jun;7:15. DOI: 10.1186/1742-6405-7-15.10.1186/1742-6405-7-15]Search in Google Scholar
[15. Tiberti N, Hainard A, Lejon V, Courtioux B, Matovu E, Enyaru JC, et al. Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness. PLoS One. 2012 Jul;7(7): e40909. DOI: 10.1371/journal.pone.0040909.10.1371/journal.pone.0040909]Search in Google Scholar
[16. Borde JP, Meier S, Fingerle V, Klier C, Hübner J, Kern WV. CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings. BMC Infect Dis. 2012 Dec;12:344. DOI: 10.1186/1471-2334-12-344.10.1186/1471-2334-12-344]Search in Google Scholar
[17. Tumani H, Cadavid D. Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis? Neurology. 2011 Mar;76(12):1034-5. DOI: 10.1212/WNL.0b013e318211c3ed.10.1212/WNL.0b013e318211c3ed]Search in Google Scholar
[18. Ciurtioux B, Pervieux L, Vatunga G, Marin B, Josenando T, Jauberteau-Marchan, et al. Increased CXCL-13 levels in human African trypanosomiasis meningoencephalitis. Trop Med Int Health. 2009 May;14(5):529-534. DOI: 10.1111/j.1365-3156.2009.02263.x.10.1111/j.1365-3156.2009.02263.x]Search in Google Scholar
[19. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurol. 2005 Aug;65(3):448-50. DOI: 10.1212/01.wnl.0000171349.06645.79.10.1212/01.wnl.0000171349.06645.79]Search in Google Scholar
[20. Senel M, Rupprecht TA, Tumani H, Pfister HW, Ludolph AC, Brettschneider J. The chemokine CXCL13 in acute neuroborreliosis. J Neurol Neurosurg Psychiatry. 2010;81(8):929-33. DOI: 10.1136/jnnp.2009.195438.10.1136/jnnp.2009.195438]Search in Google Scholar
[21. Widney DP, Breen EC, Boscardin WJ, Kitchen SG, Alcantar JM, Smith JB, et al. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J Interferon Cytokine Res. 2005 Nov;25(11):702-6. DOI: 10.1089/jir.2005.25.702.10.1089/jir.2005.25.702]Search in Google Scholar
[22. Cagigi A, Mowafi F, Phuong Dang LV, Tenner-Racz K, Atlas A, Grutzmeier S, et al. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood. 2008 Dec;112(12):4401-10. DOI: 10.1182/blood-2008-02-140426.10.1182/blood-2008-02-140426]Search in Google Scholar
[23. Rupprecht TA, Koedel U, Angele B, Fingerle V, Pfister HW. Cytokine CXCL13: a possible early CSF marker for neuroborreliosis. Nervenarzt. 2006 Apr; 77(4):470-473. DOI: 10.1007/s00115-005-2021-7.10.1007/s00115-005-2021-7]Search in Google Scholar
[24. Tjernberg L, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the Co-peptide in Lyme neuroborreliosis. J Infect. 2010 Feb;62(2):149-58. DOI: 10.1016/j.jinf.2010.11.005.10.1016/j.jinf.2010.11.005]Search in Google Scholar
[25. Sellebjerg F, Bornsen L, Khademi M, Krakaver M. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology. 2009 Dec;73(23):2003-10. DOI: 10.1212/WNL.0b013e3181c5b457.10.1212/WNL.0b013e3181c5b457]Search in Google Scholar
[26. Schiffer L, Kumpers P, Devalos AM, Haubitz M, Haller H, Anders HJ, et al. B-cell attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus. Nephrol Dial Transplant. 2009 Dec; 24(12):3780-12. DOI: 10.1093/ndt/gfp343.10.1093/ndt/gfp343]Search in Google Scholar